Review of sector Market:
This week (4.4 ~ 4.8), Shenwan beauty care sector fell – 3.52%. The Shanghai Composite Index and the gem index were – 0.94% and – 3.64% respectively. Shenwan beauty care sector lost 2.58 PCT to the Shanghai Composite Index and outperformed the gem index by 0.12 PCT.
Wind medical beauty and cosmetics index: this week, the CSI 300 index was – 1.06%, and the wind medical beauty index was – 3.34%, underperforming the CSI 300 market by 2.28pct; The wind cosmetics index was – 4.28%, underperforming the Shanghai and Shenzhen 300 market by 3.21pct.
Industry highlights:
Bechort was fined for misleading consumers with propaganda: bechort (Shanghai) Biotechnology Co., Ltd. was fined 100000 yuan for publishing publicity contents such as “Centennial pharmaceutical enterprises cooperate with Sun Yat sen University” and “producing cosmetics according to pharmaceutical standards” in its tmall online store. The product propaganda misleads consumers that there is a relationship between the product and “drug makeup”. This time or after the new regulations, the regulatory authorities issued a ticket for this kind of publicity in the industry for the first time. (Shanghai market supervision and Administration Bureau)
Company announcement:
Huadong Medicine Co.Ltd(000963) : the announcement that the holding subsidiary obtained the notice of approval for drug clinical trial was issued. The holding subsidiary of the company, Doyle bio, was finally approved by the New Zealand drug and medical device safety administration (medsafe) and the health and disability Ethics Committee (HDEC) to carry out the phase I clinical trial of dr10624 for injection locally. It is suitable for type 2 diabetes, obesity and metabolic syndrome.
Fujian Green Pine Co.Ltd(300132) : the announcement on the wholly-owned subsidiary’s acquisition of design patents was issued. The wholly-owned subsidiary northbell Cosmetics Co., Ltd. recently received the design patent certificate issued by the State Intellectual Property Office. The acquisition of patents will not have a significant impact on the current production and operation of northbell, but will help northbell further improve the intellectual property protection system and form a continuous innovation mechanism, Enhance northbell’s core competitiveness.
Hangzhou Onechance Tech Corp(300792) : the announcement on the progress of repurchasing the company’s shares was issued. As of March 31, 2022, the Company repurchased 883301 shares of the company through the special securities account for share repurchase through centralized bidding transaction, accounting for 0.37% of the total share capital of the company. The maximum transaction price was 36.69 yuan / share, the minimum transaction price was 33.88 yuan / share, and the total transaction amount was 306927 million yuan (excluding transaction costs). The implementation of repurchase meets the requirements of the company’s share repurchase plan and relevant laws and regulations.
Investment advice
(1) cosmetics industry: the sales of cosmetics enterprises in 2022q1 is expected to maintain rapid growth. According to the announcement of the company, Proya Cosmetics Co.Ltd(603605) q1 revenue increased by 30% ~ 40% year-on-year 6 Allwin Telecommunication Co.Ltd(002231) ~ February, the revenue of cosmetics increased by about 147% year-on-year, and that of Yilian Q1 Amoy increased by about 44% Bloomage Biotechnology Corporation Limited(688363) 1 ~ February revenue increased by about 55%, and the sales of mibel Q1 Amoy increased by about 56%. In the context of stricter supervision of the cosmetics industry, strong products + strong brands bring the possibility of breaking the brand circle, and continue to pay attention to the head cosmetics brands with strong R & D ability and brand strength. Attention: [ Yunnan Botanee Bio-Technology Group Co.Ltd(300957) ] subdivide the leader in the field of sensitive muscle skin care; [ Proya Cosmetics Co.Ltd(603605) ] diversified high-quality brands; [ Shanghai Jahwa United Co.Ltd(600315) ] multi category development and continuous innovation to create new items; [ Guangdong Marubi Biotechnology Co.Ltd(603983) ] focuses on medium and high-end, with rich marketing and distribution channels; [ Syoung Group Co.Ltd(300740) .
(2) medical beauty industry: the demand side of the medical beauty industry continues to expand, the supply side products are more diversified, and the policy side strengthens the supervision of medical beauty institutions and medical beauty products. We are optimistic about upstream medical and American enterprises with class III medical device certificate and perfect product matrix layout and downstream medical institutions with long-term standardized operation. Attention: [ Bloomage Biotechnology Corporation Limited(688363) ] local hyaluronic acid raw material leader; [ Imeik Technology Development Co.Ltd(300896) ] Tongyan needle is heavily listed, and differentiation meets higher demand; [ Huadong Medicine Co.Ltd(000963) ] overall layout of medical beauty business; [ Shanghai Haohai Biological Technology Co.Ltd(688366) ] integration of R & D, production and sales; [Sihuan medicine] botulinum toxin + double antibody go hand in hand; Pay attention to Lancy Co.Ltd(002612) etc. of the layout of downstream medical and aesthetic institutions.
Risk tips
The impact of repeated outbreaks; The risk of intensified industry competition; Uncertainty of industrial regulatory policies; Macroeconomic fluctuations, etc.
